BWXT Medical Ltd. – FDA 483, Mar 3, 2023
BWXT Medical Ltd in Kanata was inspected and received eight observations related to significant deficiencies in their manufacturing processes, quality control, and personnel training. The inspection revealed issues with process validation, sterility assurance, statistical procedures for testing, supplier qualification, discrepancy investigations, container testing, and test method validation, indicating a broad lack of control over critical aspects of drug product manufacturing. These findings suggest a high severity of non-compliance impacting product quality and safety.
ID · 2efbac00-9f89-458a-a6d0-c6e2dee02417
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.